XVir Therapeutics GmbH - YB-1 dependent oncolytic adenoviruses

<body bgcolor="#FDF0DE">  <b><H1>YB-1 oncolytic adenovirus cancer therapy</H1></b> <b><H2>Cancer Therapy, oncolytic dependent Onkolytische Viren, Krebstherapie Krebsforschung Krebsbekämpfung</H2><br></b> <br> YB-1 dependent oncolytic adenoviruses virus Krebsforschung Cancer Therapie therapy <a href="http://www.xvir.com">YB-1 oncolytic adenovirus cancer therapy</a> </body>


	[ News ]

Welcome to XVir® Therapeutics - The YB-1 Company®

XVir® Therapeutics GmbH is a biopharmaceutical company, which provides YB-1 dependent oncolytic adenoviruses for the treatment of cancer and in particular multidrug-resistant cancer.

Detailed information about the company will be up shortly right here with the XVir®-website! Sign up here if you wish to be informed when the site is launched:

your first name:
your last name:
your e-mail-address:

XVir® and The YB-1 Company® are registered Trademarks of XVir® Therapeutics GmbH